OptimizeRx Corporation (NASDAQ:OPRX) is expected to report third quarter earnings results, after market close, on Monday 9th November 2020.
Analysts polled by Thomson Reuters anticipate third quarter income of $ 0.04 per share.
Looking ahead, the full year income are expected at $ 0.06 per share on the revenues of $ 36.09 million.
The Company Outlook
Revenue for 3Q20 are expected in a range of $ 10.00 million ~ $ 10.00 million
Click Here For More Historical Outlooks Of OptimizeRx Corporation
Previous Quarter Performance
OptimizeRx Corporation unveiled income for the second quarter of $ 0.02 per share, from the revenue of $ 8.78 million. According to street consensus, OPRX was expected to report 2Q20 loss of $ 0.03 per share from revenue of $ 7.97 million. The bottom line results beat street analysts by $ 0.05 or 166.67 percent, at the same time, top line results outshined analysts by $ 0.81 million or 10.16 percent.
Stock Performance
On Friday, shares of OptimizeRx Corporation has traded high as $ 22.19 and has cracked $ 20.68 on the downward trend, reaching $ 21.47 with volume of 51.70 thousand shares.
According to the previous trading day, closing price of $ 21.47, representing a 232.62 % increase from the 52 week low of $ 6.50 and a 4.12 % decrease over the 52 week high of $ 22.55.
The company has a market capital of $ 322.97 million and is part of the Technology sector and Health Information Services industry.
Conference Call
OptimizeRx Corporation will be hosting a conference call at 4:30 PM eastern time on 9th November 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.optimizerx.com
OptimizeRx Corporation provides digital health messaging services for pharmaceutical companies to communicate with healthcare providers. The companys cloud-based solutions support patient adherence to medications by providing real-time access to financial assistance, prior authorization, education, and critical clinical information; and network consists of electronic health records platforms, which provide the ambulatory patient market with access to their workflow at the point-of-care. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-prescribe systems to search, print, or electronically dispense directly to patients, as well as for a network of pharmacies; and Brand and Clinical Messaging that includes various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages targeted by specialty, diagnostic code, and other criteria.
